NIH-funded research Sbir 1 grant

New coating for hemodialysis catheters to prevent infections.

Official title: Ceragenin-based antimicrobial coating to tackle hemodialysis catheter-related infections.

Funded at N8 Medical, INC. · NIH-10602612 · Data updated 2026-11-12

This study is testing a new coating for hemodialysis catheters that helps prevent infections, making it safer and more effective for patients who need dialysis.

More Hemodialysis research and trials

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionN8 Medical, INC.
NIH-funded
Lab location1 site (Dublin, UNITED STATES)
Project startSeptember 12, 2022
Project endAugust 31, 2025
Funding year2022
Award (this year)$299,155
NIH project number1R43DK133005-01A1
Project IDNIH-10602612 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing hemodialysis who are at risk for catheter-related infections.

Less likely to help

Patients who do not use hemodialysis catheters or have alternative treatment options for their kidney condition may not benefit from this research.

What this research studies

This research focuses on developing a novel antimicrobial coating for hemodialysis catheters using ceragenins, which are designed to mimic natural antimicrobial peptides. The goal is to reduce the risk of catheter-related infections, which are a significant concern for hemodialysis patients. The approach aims to enhance the effectiveness of existing treatments by preventing bacterial growth and sensitizing bacteria to antibiotics. By addressing the limitations of current antimicrobial strategies, this research seeks to improve patient outcomes and reduce healthcare costs associated with infections.

Why it matters

Potential benefit: If successful, this research could significantly lower the incidence of infections related to hemodialysis catheters, improving patient safety and reducing hospitalization costs.

How similar studies have gone: While there have been various approaches to antimicrobial coatings, the use of ceragenins represents a novel strategy that has not been extensively tested in this specific application.

Where this research is happening

  • N8 Medical, INC.
    Dublin, United States
    Active

Researchers

  • Principal investigator: Brunner, Glenn — N8 Medical, INC.
  • Study coordinator: Brunner, Glenn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.